| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/03/2010 | CA2430091C An antibiotic/analgesic formulation and a method of making this formulation |
| 08/03/2010 | CA2409828C Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 08/03/2010 | CA2407335C Process and device for producing liquid dosage formulations |
| 08/03/2010 | CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/03/2010 | CA2396524C System for stabilizing lacrimal fluid layer |
| 08/03/2010 | CA2386325C Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 08/03/2010 | CA2382223C Fat or oil composition |
| 08/03/2010 | CA2361949C Heparin, or heparin conjugate, islets of langerhans |
| 08/03/2010 | CA2306343C Novel aryloxy-alkyl-dialkylamines |
| 08/03/2010 | CA2294101C A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor |
| 08/03/2010 | CA2262423C Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 08/03/2010 | CA2247247C Troponin subunits and fragments useful as angiogenesis inhibitors |
| 08/03/2010 | CA2230748C Rapamycin formulations for oral administration |
| 08/03/2010 | CA2227706C Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 08/03/2010 | CA2224777C New immunoregulatory protein lst-1 |
| 08/03/2010 | CA2204748C Use of dioxomorpholines for combating endoparasites, new dioxomorpholines and processes for their preparation |
| 08/03/2010 | CA2188813C Angiostatin protein, nucleic acids encoding the same and methods of detection |
| 07/30/2010 | CA2691905A1 Reservoir eluting stent |
| 07/29/2010 | WO2010085820A2 Tricyclic compounds as antagonists of prostaglandin d2 receptors |
| 07/29/2010 | WO2010085811A2 Use of pterosin compounds for treating diabetes and obesity |
| 07/29/2010 | WO2010085799A2 Compositions and method for the treatment of parkinson's disease |
| 07/29/2010 | WO2010085797A2 Arginase inhibitors and methods of use |
| 07/29/2010 | WO2010085788A1 Methods of treating muscular dystrophies |
| 07/29/2010 | WO2010085753A1 Rosacea treatments and kits for performing them |
| 07/29/2010 | WO2010085749A2 Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability |
| 07/29/2010 | WO2010085724A1 Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| 07/29/2010 | WO2010085717A1 Pharmaceutical composition comprising racemic aminopterin |
| 07/29/2010 | WO2010085699A2 Mammalian piggybac transposon and methods of use |
| 07/29/2010 | WO2010085697A1 Improved vaccines for human papilloma virus and methods for using the same |
| 07/29/2010 | WO2010085684A1 Compositions and methods for inhibition of the jak pathway |
| 07/29/2010 | WO2010085661A1 Modified peptides and their use |
| 07/29/2010 | WO2010085654A1 Hedgehog pathway inhibitors |
| 07/29/2010 | WO2010085643A1 Targeting il-7 signaling as a therapy for multiple sclerosis and other il-7 signaling dependent disorders |
| 07/29/2010 | WO2010085641A1 Process for preparing particles of opioids and compositions produced thereby |
| 07/29/2010 | WO2010085609A2 Controlled release systems from polymer blends |
| 07/29/2010 | WO2010085607A1 Continuous double emulsion process for making microparticles |
| 07/29/2010 | WO2010085597A1 Macrocyclic compounds and their use as kinase inhibitors |
| 07/29/2010 | WO2010085589A2 Desensitizing drug product |
| 07/29/2010 | WO2010085584A1 Pyrazole-i, 2, 4 -oxad iazole derivatives as s.phing0sine-1-ph0sphate agonists |
| 07/29/2010 | WO2010085582A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases |
| 07/29/2010 | WO2010085581A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases |
| 07/29/2010 | WO2010085572A1 Method of treating dry eye disease with azithromycin |
| 07/29/2010 | WO2010085570A1 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors |
| 07/29/2010 | WO2010085568A1 Methods of diagnosing and treating severe dry eye syndrome |
| 07/29/2010 | WO2010085535A1 Nutritional supplements for 50+ individuals for improving vitality, immunity, eye and bone health |
| 07/29/2010 | WO2010085530A1 A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement |
| 07/29/2010 | WO2010085528A1 Bridged and fused antidiabetic compounds |
| 07/29/2010 | WO2010085525A1 Bridged and fused heterocyclic antidiabetic compounds |
| 07/29/2010 | WO2010085522A1 Pentafluorosulpholane-containing antidiabetic compounds |
| 07/29/2010 | WO2010085511A1 Method for treating prostate cancer |
| 07/29/2010 | WO2010085462A1 Method for treating triple negative breast cancer |
| 07/29/2010 | WO2010085385A1 Methods for suppressing tip dc trafficking or accumulation and preventing hypercytokinemia |
| 07/29/2010 | WO2010085377A2 Hydroxamic acid derivatives |
| 07/29/2010 | WO2010085363A1 Estrus synchronization preparations and effective cidr-less protocols |
| 07/29/2010 | WO2010085354A1 Delayed release rasagiline formulation |
| 07/29/2010 | WO2010085352A2 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use |
| 07/29/2010 | WO2010085317A1 Methods of alleviating or treating signs and/or symptoms associated with moderate to severe parkinson's disease |
| 07/29/2010 | WO2010085262A1 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 07/29/2010 | WO2010085246A1 2,4-diamino-1,3,5-triazine and 4, 6-diamino-pyrimidine derivatives and their use as aggrecanase inhibitors |
| 07/29/2010 | WO2010085158A1 Improved animal treatment |
| 07/29/2010 | WO2010085149A1 Animal feed additive and animal feed comprising alkyl esters of medium chain fatty acids, and their use in animal feed |
| 07/29/2010 | WO2010085145A1 Method for the prophylaxis or treatment of flushing |
| 07/29/2010 | WO2010085128A2 Processes for preparing hiv reverse transcriptase inhibitors |
| 07/29/2010 | WO2010085047A2 Solid pharmaceutical composition comprising amlodipine and losartan |
| 07/29/2010 | WO2010085027A1 Solid pharmaceutical composition comprising amlodipine and losartan with improved stability |
| 07/29/2010 | WO2010085014A1 Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same |
| 07/29/2010 | WO2010084979A1 Benzodiazepin-2-on derivatives |
| 07/29/2010 | WO2010084944A1 NOVEL PYRROLO[2,3-d]PYRIMIDINE COMPOUND |
| 07/29/2010 | WO2010084798A1 Tricyclic compound |
| 07/29/2010 | WO2010084797A1 Hetero atom-containing compound |
| 07/29/2010 | WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/29/2010 | WO2010084668A1 Diagnostic method for nephrotic syndrome, prophylactic or therapeutic agent for nephrotic syndrome, and method for screening the prophylactic or therapeutic agent |
| 07/29/2010 | WO2010084661A1 Composition, food, food material, pharmaceutical preparation, cosmetic and commodity each containing isothiocyanate compound |
| 07/29/2010 | WO2010084637A1 Tablet for oral administration having excellent disintegrability and dissolvability |
| 07/29/2010 | WO2010084512A1 Novel oxime derivatives |
| 07/29/2010 | WO2010084500A1 New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative |
| 07/29/2010 | WO2010084458A1 A novel dermaceutical cream made using sodium fusidate, antifungals and steroids |
| 07/29/2010 | WO2010084457A1 A novel dermaceutical cream made using sodium fusidate and steroids |
| 07/29/2010 | WO2010084438A1 Amino-heterocyclic compounds used as pde9 inhibitors |
| 07/29/2010 | WO2010084428A1 Substituted pyrazinone amides |
| 07/29/2010 | WO2010084425A1 New adenosine receptor ligands and uses thereof |
| 07/29/2010 | WO2010084384A1 Combinations of an antiplatelet agent and an antioxidant for the treatment of vascular disorders |
| 07/29/2010 | WO2010084371A1 Novel circular interfering rna molecules |
| 07/29/2010 | WO2010084356A1 Treatment of neurotrophic factor mediated disorders |
| 07/29/2010 | WO2010084275A1 Simplified method for partial genetic and epigenetic reprogramming of cells |
| 07/29/2010 | WO2010084201A1 Novel derivative of erythromycin for the treatment and diagnosis of prion disease |
| 07/29/2010 | WO2010084199A1 Drug delivery system for use in the treatment of vascular and vessel-related pathologies |
| 07/29/2010 | WO2010084188A1 Delayed-release glucocorticoid treatment of asthma |
| 07/29/2010 | WO2010084186A1 Salts and polymorphs of a kinesin inhibitor compound |
| 07/29/2010 | WO2010084185A1 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use |
| 07/29/2010 | WO2010084184A1 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use |
| 07/29/2010 | WO2010084182A1 Methods for making valerenic acid derivatives and their use |
| 07/29/2010 | WO2010084160A1 Phenylcyclopropylamine derivatives and their medical use |
| 07/29/2010 | WO2010084152A1 Novel bicyclic antibiotics |
| 07/29/2010 | WO2010084134A1 Phd2 inhibition for blood vessel normalization, and uses thereof |
| 07/29/2010 | WO2010084121A1 Novel diaza-bicyclononyl-pyrimidinyl derivatives and their medical use |
| 07/29/2010 | WO2010084120A1 N-oxides of 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine receptor ligands |
| 07/29/2010 | WO2010084111A2 Pharmaceutical composition of ibandronate sodium salt or a hydrate thereof |
| 07/29/2010 | WO2010084097A1 Spiroindolinone derivative prodrugs |
| 07/29/2010 | WO2010084066A1 Pharmaceutical composition comprising aleglitazar |